Search

1 to 10 of 147
Sort by

Library Entry
Opportunities and challenges of active immunotherapy in dogs with B-cell lymphoma: a 5-year experience in two veterinary oncology centers

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article concluding that the addition of immunotherapy to a traditional CHOP protocol is associated with improved outcome in dogs with B-cell lymphoma, regardless of histotype and evaluated prognostic factors. Moreover,...


Library Entry
Bispecific NKG2D-CD3 and NKG2D-CD16 fusion proteins for induction of NK and T cell reactivity against acute myeloid leukemia

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article introducing novel “antibody-like” BFP that takes advantage of the highly tumor-restricted expression of NKG2DL and potently activates the reactivity of NK cells or T cells for immunotherapy of AML. Authors: ...



Library Entry
STIM1 at the plasma membrane as a new target in progressive chronic lymphocytic leukemia

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article establishing the critical role of a newly discovered BCR independent Ca 2+ entry in CLL evolution, providing new insights into CLL pathophysiology, and supporting innovative therapeutic perspectives such as...


Library Entry
Immunotherapy for Treatment of Hematologic Cancers

Published in partnership with the Society for Immunotherapy of Cancer (SITC), this Patient Resource Guide provides current, medically accurate information intended specifically for patients with melanoma and their caregivers. Immunotherapy for the Treatment of Hematologic Cancers outlines...

2019 Immunotherapy Hematologic Cancers.pdf





Library Entry
Different role of circulating myeloid-derived suppressor cells in patients with multiple myeloma undergoing autologous stem cell transplantation

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article demonstrating that pre-ASCT M-MDSCs are correlated with poor clinical outcomes after ASCT through reduced cytotoxicity of melphalan. We propose that targeting CSF1R on these cells may improve the results of ASCT...